Multicancer early detection tests are among the priorities of the Biden administration’s Cancer Moonshot. The tests show promise, but questions remain about when and how to use them.
Academic rigor, journalistic flair
Articles on Cancer Moonshot
Displaying all articles
Globally, most cancer patients die not because they don’t have access to newer drugs, but because they don’t have access to even basic treatments. Cancer groundshot aims to improve treatment access.
New regulations for research with human blood and tissue try to balance scientific progress with patient privacy.
The outgoing president leaves behind some solid accomplishments in the world of science, tech and medicine. But the biggest departure from his predecessors might have been in his approach.
Top contributors
-
Associate Professor of Public Policy and Women's Studies, University of Michigan
-
Research Investigator, Obstetrics and Gynecology, University of Michigan
-
Associate Professor of Oncology and Public Health Sciences, Queen's University, Ontario
-
Professor of Laboratory Medicine and Pathology, School of Medicine, University of Washington
